Seres Therapeutics (MCRB) Assets (2016 - 2025)
Historic Assets for Seres Therapeutics (MCRB) over the last 11 years, with Q3 2025 value amounting to $143.5 million.
- Seres Therapeutics' Assets fell 1973.18% to $143.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.5 million, marking a year-over-year decrease of 1973.18%. This contributed to the annual value of $139.8 million for FY2024, which is 6101.23% down from last year.
- According to the latest figures from Q3 2025, Seres Therapeutics' Assets is $143.5 million, which was down 1973.18% from $143.8 million recorded in Q2 2025.
- Seres Therapeutics' Assets' 5-year high stood at $406.4 million during Q2 2023, with a 5-year trough of $139.8 million in Q4 2024.
- In the last 5 years, Seres Therapeutics' Assets had a median value of $311.9 million in 2022 and averaged $285.1 million.
- As far as peak fluctuations go, Seres Therapeutics' Assets skyrocketed by 17634.95% in 2021, and later tumbled by 6101.23% in 2024.
- Over the past 5 years, Seres Therapeutics' Assets (Quarter) stood at $354.9 million in 2021, then decreased by 1.71% to $348.8 million in 2022, then increased by 2.81% to $358.6 million in 2023, then plummeted by 61.01% to $139.8 million in 2024, then rose by 2.62% to $143.5 million in 2025.
- Its last three reported values are $143.5 million in Q3 2025, $143.8 million for Q2 2025, and $164.2 million during Q1 2025.